TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BMEZ

BlackRock Health Sciences Trust II

Financial Services · Asset Management · listed since 2020

16.80$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026
🔔 Watch stock
Add to watchlist

Stock Watch

Stock Watch will tell you what changes at BlackRock Health Sciences Trust II.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 13.80 $ to 17.30 $ · Last price: 16.80 $ (As of: September 25, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 1.0$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 63m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. –
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. –

Performance

Perf. 1M ?Price performance over the last month. 5.10%
Perf. 3M ?Price performance over the last 3 months. 14.40%
Perf. 6M ?Price performance over the last 6 months. 7.20%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 7.31%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. 0.0%
Perf. 1Y ?Price performance over the last 12 months. 29.48%
Perf. 3Y ?Price performance over the last 3 years. 63.86%
Perf. 5Y ?Price performance over the last 5 years. 3.56%
Perf. Since Inception ?Price performance since the first available trading day (01/29/2020) — with a complete history, that is since the IPO. 53.84%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 16.50$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 16.20$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 15.10$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 57.2
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 22.9%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 16.4%

Calculated from the price history · as of 09/25/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. 6.6
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 0.0
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. –
P/B ?Price-to-book ratio: market value relative to book equity. 1.0
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. –
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 0.0
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. –

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. –
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. 0.0%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 0.0%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 0.0%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 0.0%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 99.2%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.00
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. –
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 5 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 193.79%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. –
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. –

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. –
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. –
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. –
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. D (42 out of 100)

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Asset Management

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
BlackRock Health Sciences Trust II BMEZ 1.0 6.6 0.0 – 0.0 193.8 29.5
BlackRock Inc BLK 183.2 27.3 14.9 47.2 35.6 18.7 -3.3
Blackstone Group Inc BX 148.6 30.3 15.7 100.0 38.0 21.6 -29.8
KKR & Co. Inc. KKR 93.4 32.6 1.1 54.8 11.0 -11.0 -30.2
Apollo Global Management, Inc. APO 72.6 76.7 7.9 36.1 13.5 16.0 -10.6
Brookfield Asset Management Ltd. BAM 71.7 28.5 18.2 74.4 64.5 15.8 -20.1
State Street Corp STT 50.4 18.4 0.0 100.0 27.8 3.0 64.4
Ameriprise Financial Inc AMP 44.8 12.4 0.0 54.9 37.2 9.6 -0.1
Ares Management LP ARES 41.9 56.1 18.4 37.4 18.4 66.6 -21.8
Median of companies shown 71.7 28.5 7.9 54.8 27.8 16.0 -10.6

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2019 · Revenue: 114 $M 2019 · Net income: 113 $M 2020 · Revenue: 5 $M 2020 · Operating income: 0 $M 2020 · Net income: 80 $M 2021 · Revenue: 60 $M 2021 · Operating income: 0 $M 2021 · Net income: 59 $M 2022 · Revenue: -26 $M 2022 · Operating income: 2 $M 2022 · Net income: -26 $M 2023 · Revenue: 8 $M 2023 · Operating income: 8 $M 2023 · Net income: 20 $M 2024 · Revenue: 24 $M 2024 · Operating income: 1 $M 2024 · Net income: 23 $M
201920202021202220232024
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2019 114 – 113 1.00 -1,515 1,636 1,729
2020 5 0 80 0.71 107 3,024 555
2021 60 0 59 0.52 -22 626 649
2022 -26 2 -26 -2.10 -1 600 606
2023 8 8 20 1.44 32 588 596
2024 24 1 23 1.77 66 769 775

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q2 · -0.4 $M Q2 2024: Q4 · 24.5 $M Q4

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q2 – – 0 -102.30 – -13 -13
2024: Q4 – – 25 33.70 -92.00 79 79

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

AI classification

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.

How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

6 of 10 Solid growth
  • Revenue grows by more than 15% a year over three years -26.1%
  • More than 10% revenue growth is expected for the coming year no data
  • Share count grows by less than 3% a year -51.0%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 466.0%
  • Gross margin at 40% or higher and without meaningful erosion 100.0%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA 26 m net cash
  • Operating cash flow covers the profits of the last three years 80 m
  • Return on capital at 15% or higher, or up versus two years ago no data
  • Insiders hold at least 10% or are net buyers 0.0%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

3/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% -26.7%
  • Exp. sales growth 3Y > 5% –
  • EBIT growth 10Y > 5% 90.9%
  • Exp. EBIT growth 3Y > 5% –
  • Net debt < 4x EBIT -28.3x
  • EBIT positive, 10Y straight 5
  • Max. EBIT decline < 50% 89.0%
  • Return on equity > 15% 3.1%
  • ROCE > 15% –
  • Expected return > 10% –

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

The company

About the Company

Headquarters
New York, NY
Address
50 Hudson Yards, 10001 New York, United States
Phone
212-810-5300
IPO Date
01/29/2020
ISIN
US09260E1055

Management

Management
Name Title Birth Year
Xiang Liu Ph.D. Portfolio Manager –

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?